Related references
Note: Only part of the references are listed.Nrf2 Activation: Involvement in Central Nervous System Traumatic Injuries. A Promising Therapeutic Target of Natural Compounds
Serena Silvestro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Targeting tumor cells with pyrazolo[3,4-d] pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms
Mohamed A. Abdelgawad et al.
ARABIAN JOURNAL OF CHEMISTRY (2022)
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma
Enrico Rango et al.
BIOMEDICINES (2022)
A Novel Pyrazolo[3,4-d]pyrimidine Induces Heme Oxygenase-1 and Exerts Anti-Inflammatory and Neuroprotective Effects
Ji Ae Lee et al.
MOLECULES AND CELLS (2022)
Diversity and versatility of p38 kinase signalling in health and disease
Begona Canovas et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Thio-substituted derivatives of 4-amino-pyrazolo[3,4-d]pyrimidine-6-thiol as antiproliferative agents
Barbara Cacciari et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells
Ana Kostic et al.
BRAIN SCIENCES (2021)
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Helmut Sies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-d]pyrimidines Kinase Inhibitors
Chiara Greco et al.
MOLECULES (2020)
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds
Noor Atatreh et al.
BIOORGANIC CHEMISTRY (2019)
COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core
Eman K. A. Abdelall et al.
BIOORGANIC CHEMISTRY (2019)
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents
Gina N. Tageldin et al.
BIOORGANIC CHEMISTRY (2018)
New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds
Khaled R. A. Abdellatif et al.
BIOORGANIC CHEMISTRY (2018)
Clinical translation of immunoliposomes for cancer therapy: recent perspectives
Di Wang et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation
Yue Jin et al.
ONCOTARGET (2016)
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery
Giulia Vignaroli et al.
SCIENTIFIC REPORTS (2016)
Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies
Silvia Schenone et al.
CHEMICAL REVIEWS (2014)
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors
Giulia Vignaroli et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-α: Hit to lead studies
Adam M. Gilbert et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors
Elena Dreassi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Share Paper
